Table 6 5ARI users with PIRADS 3 index lesion
From: 5-alpha reductase inhibitors and MRI prostates: actively reducing prostate sizes and ambiguity
Overall cancers (n = 8) | No cancers (n = 15) | Clinically significant cancers (n = 2) | No Clinically significant cancers (n = 21) | |
|---|---|---|---|---|
Patients with prior negative biopsy | 1 (12.5%) | 8 (53.3%) | 1 (50.0%) | 8 (38.1%) |
PSA | 8.59 | 15.01 | 8.64 | 13.17 |
Corrected PSA | 17.2 | 30.0 | 17.3 | 26.3 |
PSA density | 0.174 | 0.200 | 0.182 | 0.191 |
Corrected PSA density | 0.347 | 0.400 | 0.364 | 0.383 |
Abnormal DRE | 0 (0%) | 4 (26.7%) | 0 (0%) | 4 (19.0%) |
PHI | 41.8 | 35.0 | – | 37.4 |
PHI density | 0.923 | 0.487 | – | 0.643 |